Last quarter (Q2 2025), Diagnos's total revenue was $22.67K, a decrease of -30.68% from the same quarter last year. In Q2, Diagnos's net income was $-1.02M. See Diagnos’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Total Revenue	$ 153.49K	$ 170.16K	$ 513.09K	$ 538.95K	$ 267.07K	$ 331.52K
Cost of Revenue	$ 949.97K	$ 1.01M	$ ―	$ 857.13K	$ 614.60K	$ 804.97K
Gross Profit	$ -796.47K	$ -837.94K	$ 513.09K	$ 538.95K	$ -347.53K	$ -473.45K
Operating Expense	$ 1.80M	$ 1.77M	$ 2.72M	$ 3.39M	$ 2.68M	$ 2.48M
Operating Income	$ -2.82M	$ -2.61M	$ -2.21M	$ -2.85M	$ -3.03M	$ -2.95M
Net Non Operating Interest Income Expense	$ -573.93K	$ -543.28K	$ -278.92K	$ -53.78K	$ -69.21K	$ -343.88K
Other Income Expense	$ -25.98K	$ -30.01K	$ ―	$ -25.00	$ -256.43K	$ -88.64K
Pretax Income	$ -3.35M	$ -3.12M	$ -2.48M	$ -2.92M	$ -2.85M	$ -3.21M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -3.35M	$ -3.12M	$ ―	$ -2.92M	$ -2.85M	$ -3.21M
Basic EPS	$ -0.04	$ -0.04	$ ―	$ -0.04	$ -0.03	$ -0.08
Diluted EPS	$ -0.04	$ -0.04	$ ―	$ -0.04	$ -0.03	$ -0.08
Basic Average Shares	$ 308.18M	$ 72.82M	$ ―	$ 68.73M	$ 63.11M	$ 40.74M
Diluted Average Shares	$ 308.18M	$ 72.82M	$ ―	$ 68.73M	$ 63.11M	$ 40.74M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 1.23M	$ ―	$ ―	$ 3.39M	$ -2.55M	$ -3.13M
Net Income From Continuing And Discontinued Operation	$ -3.35M	$ -3.12M	$ ―	$ -2.92M	$ -2.85M	$ -3.21M
Normalized Income	$ -2.91M	$ -2.29M	$ -1.82M	$ -2.14M	$ -2.09M	$ -2.36M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -2.78M	$ -2.58M	$ -2.20M	$ -2.86M	$ -2.80M	$ -2.86M
EBITDA	$ -2.69M	$ -2.47M	$ -2.10M	$ -2.77M	$ -1.91M	$ -2.76M

Currency in USD

Diagnos Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing